Patent · US Active

Compositions and methods for inhibiting gene expression of hepatitis B virus

US8809293B2 · kind B2 · utility

35Cited by

50References

17Claims

0Family size

Assignee

Arrowhead Madison, Inc. · US

Inventors

Daniel Chin · Foster City, US
Jochen Deckert · Bayreuth, DE
Markus Hossbach · Kulmbach, DE
Matthias John · Hallstadt, DE

Key dates

Filing date	Jun 28, 2012
Grant date	Aug 19, 2014
Priority date	—
Expiry date	Aug 15, 2032

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2310/3521
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to a double-stranded ribonucleic acid (dsRNA) for inhibiting the expression of a Hepatitis B Virus gene. The invention also relates to a pharmaceutical composition comprising the dsRNA or nucleic acid molecules or vectors encoding the same together with a pharmaceutically acceptable carrier; methods for treating diseases caused by Hepatitis B Virus infection using said pharmaceutical composition; and methods for inhibiting the expression of a Hepatitis B Virus gene in a cell.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.